Current diagnosis and management of gastrointestinal neuroendocrine tumours

Digestive and Liver Disease

Volumn 33, Issue 3, 2001, Pages 212-214

  Jensen, R T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHROMOGRANIN; DOXORUBICIN; FLUOROURACIL; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; STREPTOZOCIN;

ARTICLE; CARCINOID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TUMOR; HUMAN; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; SCINTIGRAPHY; SIDE EFFECT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING; TUMOR LOCALIZATION;

EID: 0035013369     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(01)80708-8     Document Type: Article

References (25)

1. R.T. Jensen G.M. Doherty Carcinoid tumors and the carcinoid syndrome V.T. DeVita Jr S. Hellman S.A. Rosenberg Cancer: Principles and practice of oncology 6th ed. 2000 Lippincott Williams & Wilkins Philadelphia 1813 1833
2. R.A. Alexander R.T. Jensen Pancreatic endocrine tumors V.T. DeVita S. Hellman S.A. Rosenberg Cancer: Principles and practice of oncology 6th ed. 2000 Lippincott Williams & Wilkins Philadelphia 1788 1813
3. R.T. Jensen Natural history of digestive endocrine tumors M. Mignon J.F. Colombel Recent advances in pathophysiology and management of inflammatory bowel diseases and digestive endocrine tumors 1999 John Libbey Eurotext Paris 192 219
4. M. Mignon Natural history of neuroendocrine enteropancreatic tumors Digestion 62 2000 51 58
5. O. Schillaci F. Scopinaro R. Danieli S. Angeletti R. Tavolaro B. Annibale Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids Anticancer Res 17 1997 1753 1756
6. E.P. Krenning D.J. Kwekkeboom H.Y. Oei R.J.B. de Jong F.J. Dop J.C. Reubi Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors Ann NY Acad Sci 733 1994 416 424
7. D. Kwekkeboom E.P. Krenning M. deJong Peptide receptor imaging and therapy J Nucl Med 41 2000 1704 1713
8. C.H. van Eijck S.W. Lamberts L.C. Lemaire H. Jeekel F.T. Bosman J.C. Reubi The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors Ann Surg 224 1996 119 124
9. B. Eriksson Tumor markers for pancreatic endocrine tumors, including chromogranins, HCG-alpha and HCG-beta M. Mignon R.T. Jensen Endocrine tumors of the pancreas: Recent advances in research and management 3rd ed. Series: Frontiers of Gastrointestinal Research vol. 23 1995 S. Karger Basel 121 131
10. F.R. Nobels D.J. Kwekkeboom W. Coopmans C.H. Schoenmakers J. Lindemans W.W. de Herder Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuronspecific enolase and the alpha-subunit of glycoprotein hormones J Clin Endocrinol Metab 82 1997 2622 2628
11. M. Stridsberg K. Oberg Q. Li U. Engstrom G. Lundqvist Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours J Endocrinol 144 1995 49 59
12. R.T. Jensen Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment Curr Opin Oncol 12 2000 368 377
13. J. Rubin J. Ajani W. Schirmer A.P. Venook R. Bukowski R. Pommier Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome J Clin Oncol 17 1999 600 606
14. P. Tomassetti M. Mighori R. Corinaldesi L. Gullo Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR Aliment Pharmacol Ther 14 2000 557 560
15. S. Ricci A. Antonuzzo L. Galli M. Ferdeghini L. Bodei C. Orlandini Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Ann Oncol 11 2000 1127 1130
16. S. Angeletti V.D. Corleto O. Schillaci A. Moretti F. Panzuto B. Annibale Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours Ital J Gastroenterol Hepatol 31 1999 23 27
17. M. Ducreux P. Ruszniewski J.A. Chayvialle J. Blumberg D. Cloarec H. Michel The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors Am J Gastroenterol 95 2000 3276 3281
18. B. Eriksson J. Renstrup H. Imam K. Oberg High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects Ann Oncol 8 1997 1041 1044
19. H. Imam B. Eriksson A. Lukinius E.T. Janson P.G. Lindgren E. Wilander Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs Acta Oncol 36 1997 607 614
20. D.M. Nagorney F.G. Que Cytoreductive hepatic surgery for metastatic gastrointestinal neuroendocrine tumors M. Mignon R.T. Jensen Endocrine tumors of the pancreas: Recent advances in research and management 3rd ed. Series: Frontiers of Gastrointestinal Research Vol. 23 1995 S. Karger Basel 416 430
21. P. Pederzoli M. Falconi A. Bonora R. Salvia N. Sartori C. Contro Cytoreductive surgery in advanced endocrine tumours of the pancreas Ital J Gastroenterol Hepatol 31 1999 S207 S212
22. V.D. Corleto F. Panzuto M. Falconi R. Cannizzaro S. Angeletti A. Moretti Digestive neuroendocrine tumors: diagnosis and treatment in Italy Digest Liver Dis 33 2001 217 221
23. S.U. Goebel J. Serrano F. Yu F. Gibril D.J. Venzon R.T. Jensen Prospective study of the value of serum chromogranin A or serum gastrin levels in assessment of the presence, extent, or growth of gastrinomas Cancer 85 1999 1470 1483
24. R.T. Jensen J.A. Norton Endocrine neoplasms of the pancreas 3rd ed. T. Yamada D.H. Alpers C. Owyang D.W. Powell F.E. Silverstein Textbook of gastroenterology 1998 JB Lippincott Philadelphia 2193 2228
25. R.J. Pelley R.M. Bukowski Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors Curr Opin Oncol 11 1999 32 37